In other countries
The same active substances on other registers, the same brand first.
- JeraygoEuropean Union · Idorsia Pharmaceuticals Deutschland GmbHSame brand
- JeraygoCroatiaSame brand
- JERAYGO 12,5 mg filmomhulde tablettenNetherlands · Filmomhulde tablet · Idorsia Pharmaceuticals Deutschland GmbHSame brand
- JERAYGO 25 mg filmomhulde tablettenNetherlands · Filmomhulde tablet · Idorsia Pharmaceuticals Deutschland GmbHSame brand
- TryvioUnited States · 12.5MG · tablet · IdorsiaSame form
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Aprocitentan
- Strength
- 25 MG
- Dosage form
- Tablet
- Route
- Oral
- Register
- Canada (Health Canada)
- Status
- Authorised
- Status in the register
- Approved
- Registration
- DIN 02563991
- Marketing authorisation holder
- Idorsia Pharmaceuticals LTD
- ATC code
- C02KN01
- Supply
- PRESCRIPTION



